Tissue factor pathway inhibitor induces expression of JUNB and GADD45B mRNAs

Tissue factor pathway inhibitor (TFPI) is a Kunitz-type protease inhibitor that regulates tissue factor-triggered blood coagulation. It has previously been reported that TFPI inhibits the proliferation of human umbilical vein endothelial cells (HUVECs), suggesting that TFPI may act as more than just...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 299; no. 5; pp. 847 - 852
Main Authors Shirotani-Ikejima, Hiroko, Kokame, Koichi, Hamuro, Tsutomu, Bu, Guojun, Kato, Hisao, Miyata, Toshiyuki
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 20.12.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tissue factor pathway inhibitor (TFPI) is a Kunitz-type protease inhibitor that regulates tissue factor-triggered blood coagulation. It has previously been reported that TFPI inhibits the proliferation of human umbilical vein endothelial cells (HUVECs), suggesting that TFPI may act as more than just a mediator of coagulation through changes in gene expression. By using DNA-array techniques and Northern blot analysis, we here revealed that TFPI transiently induced the mRNA expression of JUNB and GADD45B. The inducible effects were not observed in TFPIΔC (lacking the C-terminal basic region) or antithrombin (heparin-binding anticoagulant protease inhibitor). Moreover, the TFPI-induced expression of GADD45B was blocked by receptor-associated protein, which masks the ligand-binding domain of very low density lipoprotein receptor (VLDL-R). In conclusion, this is the first report to show an effect of TFPI on mRNA expression, and suggests that TFPI modulates cellular functions by inducing JUNB and GADD45B expression through binding to VLDL-R.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/S0006-291X(02)02759-6